Showing results (1731-1740 of 1,802) with videos related to
Sort By:
Pageof 181
Journal of Neurodevelopmental Disorders|October 26, 2016
Uncovering obsessive-compulsive disorder risk genes in a pediatric cohort by high-resolution analysis of copy number variationMatthew J Gazzellone, Mehdi Zarrei, Christie L Burton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2018
Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III MelanomaAxel Hauschild, Reinhard Dummer, Dirk Schadendorf, et al.Cell Reports|August 2, 2025
Plasma extracellular vesicle surface-located GAS6/PROS1 and CD39/CD73 attenuate inflammationMartina P Fabiano, Alan M Adamczyk, Olesia A Gololobova, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 18, 2026
Selective Impact on Regulatory T cell with Sustained Functional Phenotype by the IL-2 Mutein VIS171 in a Nonhuman Primate ModelDavide Schiliró, Matt Tunbridge, Nolan J Brown, et al.International Journal of Stroke : Official Journal of the International Stroke Society|December 25, 2024
Ischemic stroke prevention in patients with atrial fibrillation and a recent ischemic stroke, TIA, or intracranial hemorrhage: A World Stroke Organization (WSO) scientific statementLuciano A Sposato, Alan C Cameron, Michelle C Johansen, et al.European Journal of Cancer (Oxford, England : 1990)|May 15, 2017
Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFV600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysisChristian U Blank, James Larkin, Ana M Arance, et al.Transplantation and Cellular Therapy|April 29, 2023
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin LymphomaNausheen Ahmed, William Wesson, Muhammad Umair Mushtaq, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2017
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced MelanomaMario Sznol, Pier Francesco Ferrucci, David Hogg, et al.The New England Journal of Medicine|June 20, 2024
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III MelanomaGeorgina V Long, Axel Hauschild, Mario Santinami, et al.Epilepsy & Behavior : E&B|August 13, 2015
Third International Congress on Epilepsy, Brain, and Mind: Part 2Ivan Rektor, Steven C Schachter, Ravindra Arya, et al.Pageof 181